Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

3.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.4K
ER Retrieval Pathway01:45

ER Retrieval Pathway

4.9K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
4.9K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

5.4K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.4K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

5.0K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
5.0K
Overview of Protein Sorting and Transport01:45

Overview of Protein Sorting and Transport

23.2K
Eukaryotic cells have different membrane-bound organelles with distinct protein requirements. The process by which proteins are targeted to a specific organelle is called protein sorting.
Protein sorting can be of two types: signal-based sorting and vesicle-based trafficking. In signal-based sorting, specific amino acid sequences called sorting signals target proteins to the proper location inside the cell either via gated transport or by protein translocation.  In gated transport, folded...
23.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of convolutional neural networks for automated brain-wide histopathological analysis in mouse models of synucleinopathies.

NPJ Parkinson's disease·2025
Same author

A deep phenotyping study in mouse and iPSC models to understand the role of oligodendroglia in optic neuropathy in Wolfram syndrome.

Acta neuropathologica communications·2024
Same author

Skeletal muscle overexpression of sAnk1.5 in transgenic mice does not predispose to type 2 diabetes.

Scientific reports·2023
Same author

Neuroprotective properties of anti-apoptotic BCL-2 proteins in 5xFAD mouse model of Alzheimer's disease.

IBRO neuroscience reports·2023
Same author

Cellular and molecular features related to exceptional therapy response and extreme long-term survival in glioblastoma.

Cancer medicine·2023
Same author

Clinical, electrophysiological and genetic characteristics of childhood hereditary polyneuropathies.

Revue neurologique·2020

Related Experiment Video

Updated: Mar 5, 2026

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

7.6K

ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated

S Demirsoy1, S Martin2, S Motamedi1

  • 1Laboratory for Cell Death Research and Therapy, Department of Cellular and Molecular Medicine, University of Leuven (KU Leuven).

Human Molecular Genetics
|March 24, 2017
PubMed
Summary

ATP13A2 protein helps clear toxic proteins during cellular stress by facilitating cargo export via nanovesicles. Its scaffolding role, independent of its ATPase activity, is crucial for cellular proteostasis in Parkinson's disease models.

More Related Videos

Author Spotlight: Imaging ATG9A, a Multi-Spanning Membrane Protein
07:20

Author Spotlight: Imaging ATG9A, a Multi-Spanning Membrane Protein

Published on: June 16, 2023

2.8K
Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
11:05

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells

Published on: February 21, 2019

9.7K

Related Experiment Videos

Last Updated: Mar 5, 2026

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

7.6K
Author Spotlight: Imaging ATG9A, a Multi-Spanning Membrane Protein
07:20

Author Spotlight: Imaging ATG9A, a Multi-Spanning Membrane Protein

Published on: June 16, 2023

2.8K
Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
11:05

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells

Published on: February 21, 2019

9.7K

Area of Science:

  • Cell Biology
  • Neuroscience
  • Genetics

Background:

  • ATP13A2 (PARK9) is a lysosomal ATPase linked to Parkinson's disease (PD) and Kufor-Rakeb Syndrome (KRS).
  • Its function in stressed cells, particularly its N-terminal domain, remains poorly understood.
  • Understanding ATP13A2's role is vital for neurodegenerative disease research.

Purpose of the Study:

  • To investigate the physiological role of ATP13A2 in cells experiencing proteotoxic stress.
  • To elucidate the function of ATP13A2's N-terminal domain and its catalytic activity.
  • To determine ATP13A2's involvement in protein degradation pathways and vesicular trafficking.

Main Methods:

  • Generated cell lines overexpressing wild-type (WT), catalytically inactive (D508N), and N-terminal mutants of ATP13A2, alongside shRNA for ATP13A2 silencing.
  • Induced proteotoxic stress using Bortezomib (proteasome inhibitor).
  • Analyzed ubiquitin-conjugated protein accumulation, autophagic degradation, endocytic vesicle relocation, and nanovesicle cargo export.
  • Investigated the role of PI(3,5)P2 binding and PIKfyve in ATP13A2-mediated trafficking.

Main Results:

  • Overexpression of WT or mutant ATP13A2 reduced intracellular ubiquitin-protein accumulation under proteotoxic stress, independent of autophagy.
  • ATP13A2 silencing exacerbated ubiquitin-protein accumulation, mirroring KRS patient phenotypes.
  • ATP13A2 promoted endocytic vesicle relocation and enhanced cargo export via nanovesicles.
  • Impaired PI(3,5)P2 binding or PIKfyve inhibition disrupted trafficking and rescued protein accumulation.

Conclusions:

  • ATP13A2 plays a crucial, activity-independent scaffolding role in trafficking and exporting intracellular cargo during proteotoxic stress.
  • This function is vital for maintaining proteostasis and may be a therapeutic target for Parkinson's disease.
  • The PI(3,5)P2 pathway is integral to ATP13A2's stress-response mechanism.